🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiang Qin

Johnson & Johnson (United States)

ORCID: 0000-0003-1524-027X

Also affiliated with Baylor College of Medicine, Northwest Institute of Eco-Environment and Resources

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.8Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals

PLoS ONE(2021)10.1371/journal.pone.0244468
Top 12%
1.8DataRank
Top 12%37 citations

Sara Javornik Cregeen, Richard Sucgang, Qingchang Meng, Xiang Qin, Vasanthi Avadhanula +16 more

Papers

Driven by 9 papers — median percentile 88. Top paper: “Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals”.

Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals

PLoS ONE(2021)10.1371/journal.pone.0244468
Top 12%
1.8DataRank
Top 12%37 citations

Sara Javornik Cregeen, Richard Sucgang, Qingchang Meng, Xiang Qin, Vasanthi Avadhanula +16 more

The emerging genomics and systems biology research lead to systems genomics studies

BMC Genomics(2014)10.1186/1471-2164-15-s11-i1
N/A
0.646DataRank · unranked
73 citations

Kenji Yoshigoe, William Yang, Weida Tong, Xiang Qin, A Keith Dunker +6 more

Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study

Genetics in Medicine(2022)10.1016/j.gim.2022.01.022
N/A
0.637DataRank · unranked
69 citations

Steven E. Scherer, Suzette J. Bielinski, Donna M. Muzny, Leila A. Jones, John L. Black +95 more

CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis

Journal of Molecular Diagnostics(2022)10.1016/j.jmoldx.2021.12.011
N/A
0.581DataRank · unranked
47 citations

Erin C. Boone, Steven E. Scherer, Seung‐been Lee, Ibrahim Numanagić, S. Cenk Şahinalp +13 more

Inter and intra-host diversity of RSV in hematopoietic stem cell transplant adults with normal and delayed viral clearance

Virus Evolution(2023)10.1093/ve/vead086
N/A
0.373DataRank · unranked
11 citations

Daniel Paiva Agustinho, Vipin K. Menon, Roy F. Chemaly, Dimpy P. Shah, Xiang Qin +10 more

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease

UNC Libraries(2020)10.17615/tfn8-cp59
N/A
0DataRank · unranked
0 citations

Ming Qi, Peter M. Voorhees, Frits van Rhee, Razelle Kurzrock, Luis Fayad +5 more

Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1

Cells(2022)10.3390/cells11152461
N/A
0DataRank · unranked
11 citations

Vitalyi Senyuk, Ke Ma, Hui Chen, Xiang Qin, Shun Li +4 more

Functional Genomics of Gastrointestinal Escherichia coli Isolated from Patients with Cancer and Diarrhea

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.31.543115
N/A
0DataRank · unranked
0 citations

Justin R. Clark, Lily G. Carlin, Ellen E. Vaughan, Anubama Rajan, Adilene Olvera +22 more

A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

UNC Libraries(2020)10.17615/tmgg-w910
N/A
0DataRank · unranked
0 citations

Suzanne Lentzsch, Pieter Sonneveld, Sonja Zweegman, Hong Xie, Xiang Qin +13 more